Article Versions Notes

Skok K, Gradišnik L, Čelešnik H, Milojević M, Potočnik U, Jezernik G, Gorenjak M, Sobočan M, Takač I, Kavalar R, et al. MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines. Cells. 2022; 11(1):117. https://doi.org/10.3390/cells11010117

Skok, Kristijan, Lidija Gradišnik, Helena Čelešnik, Marko Milojević, Uroš Potočnik, Gregor Jezernik, Mario Gorenjak, Monika Sobočan, Iztok Takač, Rajko Kavalar, and et al. 2022. "MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines" Cells 11, no. 1: 117. https://doi.org/10.3390/cells11010117

Skok, K., Gradišnik, L., Čelešnik, H., Milojević, M., Potočnik, U., Jezernik, G., Gorenjak, M., Sobočan, M., Takač, I., Kavalar, R., & Maver, U. (2022). MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines. Cells, 11(1), 117. https://doi.org/10.3390/cells11010117